Literature DB >> 16211008

Distinct E2F-mediated transcriptional program regulates p14ARF gene expression.

Hideyuki Komori1, Mitsuru Enomoto, Masataka Nakamura, Ritsuko Iwanaga, Kiyoshi Ohtani.   

Abstract

The tumor suppressor p14(ARF) gene is induced by ectopically expressed E2F, a positive regulator of the cell cycle. The gene is expressed at low levels in normally growing cells in contrast to high levels in varieties of tumors. How p14(ARF) gene is regulated by E2F in normally growing cells and tumor cells remains obscure. Here we show that regulation of p14(ARF) gene by E2F is distinct from that of classical E2F targets. It is directly mediated by E2F through a novel E2F-responsive element that varies from the typical E2F site. The element responds to E2F activity resulting from ectopic E2F1 expression, inactivation of pRb by adenovirus E1a or shRNA, but not to phosphorylation of pRb by serum stimulation or ectopic cyclin D1/cyclin-dependent kinase-4 expression in normal human fibroblasts. The element has activity in various tumor cells with defective pRb, but not in normally growing cells. These results indicate that the distinct regulation constitutes the basis of p14(ARF) function as a tumor suppressor, discriminating abnormal growth signals caused by defects in pRb function from normal growth signals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16211008      PMCID: PMC1276720          DOI: 10.1038/sj.emboj.7600836

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.

Authors:  S W Hiebert; S P Chellappan; J M Horowitz; J R Nevins
Journal:  Genes Dev       Date:  1992-02       Impact factor: 11.361

2.  Role of the INK4a locus in tumor suppression and cell mortality.

Authors:  M Serrano; H Lee; L Chin; C Cordon-Cardo; D Beach; R A DePinho
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

Review 3.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

4.  p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens.

Authors:  S D Morgenbesser; B O Williams; T Jacks; R A DePinho
Journal:  Nature       Date:  1994-09-01       Impact factor: 49.962

5.  Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.

Authors:  Frederique Zindy; Richard T Williams; Troy A Baudino; Jerold E Rehg; Stephen X Skapek; John L Cleveland; Martine F Roussel; Charles J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-09       Impact factor: 11.205

6.  Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.

Authors:  Julien Sage; Abigail L Miller; Pedro A Pérez-Mancera; Julianne M Wysocki; Tyler Jacks
Journal:  Nature       Date:  2003-07-10       Impact factor: 49.962

7.  Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues.

Authors:  Kathleen A O'Leary; Susan M Mendrysa; Abram Vaccaro; Mary Ellen Perry
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.

Authors:  Aaron Aslanian; Phillip J Iaquinta; Raluca Verona; Jacqueline A Lees
Journal:  Genes Dev       Date:  2004-06-02       Impact factor: 11.361

9.  Cell cycle-regulated expression of mammalian CDC6 is dependent on E2F.

Authors:  G Hateboer; A Wobst; B O Petersen; L Le Cam; E Vigo; C Sardet; K Helin
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

10.  The tumor-suppressive functions of the human INK4A locus.

Authors:  P Mathijs Voorhoeve; Reuven Agami
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

View more
  23 in total

1.  Jab1/CSN5 mediates E2F dependent expression of mitotic and apoptotic but not DNA replication targets.

Authors:  Huarui Lu; Xudong Liang; Olga A Issaenko; Timothy C Hallstrom
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

2.  DNA damage signals through differentially modified E2F1 molecules to induce apoptosis.

Authors:  Jasmyne Carnevale; Oliva Palander; Laurie A Seifried; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2011-12-19       Impact factor: 4.272

Review 3.  Surprising dependency for retinoblastoma protein in ras-mediated tumorigenesis.

Authors:  James DeGregori
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

Review 4.  Network calisthenics: control of E2F dynamics in cell cycle entry.

Authors:  Jeffrey V Wong; Peng Dong; Joseph R Nevins; Bernard Mathey-Prevot; Lingchong You
Journal:  Cell Cycle       Date:  2011-09-15       Impact factor: 4.534

5.  Modeling the response of a tumor-suppressive network to mitogenic and oncogenic signals.

Authors:  Xinyu Tian; Bo Huang; Xiao-Peng Zhang; Mingyang Lu; Feng Liu; José N Onuchic; Wei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

6.  Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation.

Authors:  A Kumari; T Iwasaki; S Pyndiah; E K Cassimere; C D Palani; D Sakamuro
Journal:  Cell Death Differ       Date:  2014-09-26       Impact factor: 15.828

Review 7.  p53 and E2f: partners in life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

8.  Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.

Authors:  John T Minges; Gail Grossman; Ping Zhang; Tal Kafri; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2015-09-01       Impact factor: 5.157

9.  The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.

Authors:  Yi-Hung Ou; Pei-Han Chung; Fu-Fei Hsu; Te-Ping Sun; Wen-Ying Chang; Sheau-Yann Shieh
Journal:  EMBO J       Date:  2007-08-09       Impact factor: 11.598

10.  Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.

Authors:  Xingwu Wang; Meng Zha; Xiaocheng Zhao; Peng Jiang; Wenjing Du; Andrew Y H Tam; Yide Mei; Mian Wu
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.